Cite
HARVARD Citation
Symonds, R. et al. (2015). Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet oncology. 16 (15), pp. 1515-1524. [Online].